Class information for:
Level 1: ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
974 2836 35.9 78%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
81 26583 MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACUTE MYELOID LEUKEMIA Author keyword 108 16% 22% 616
2 GEMTUZUMAB OZOGAMICIN Author keyword 75 61% 3% 80
3 AML Author keyword 32 12% 9% 255
4 ACUTE MYELOID LEUKAEMIA Author keyword 25 17% 5% 135
5 CYTARABINE Author keyword 23 21% 4% 100
6 POSTREMISSION THERAPY Author keyword 19 76% 0% 13
7 HIGH DOSE CYTARABINE Author keyword 15 49% 1% 22
8 VORELOXIN Author keyword 15 88% 0% 7
9 GEMTUZUMAB Author keyword 13 71% 0% 10
10 ACUTE MYELOGENOUS LEUKEMIA Author keyword 11 13% 3% 79

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ACUTE MYELOID LEUKEMIA 108 16% 22% 616 Search ACUTE+MYELOID+LEUKEMIA Search ACUTE+MYELOID+LEUKEMIA
2 GEMTUZUMAB OZOGAMICIN 75 61% 3% 80 Search GEMTUZUMAB+OZOGAMICIN Search GEMTUZUMAB+OZOGAMICIN
3 AML 32 12% 9% 255 Search AML Search AML
4 ACUTE MYELOID LEUKAEMIA 25 17% 5% 135 Search ACUTE+MYELOID+LEUKAEMIA Search ACUTE+MYELOID+LEUKAEMIA
5 CYTARABINE 23 21% 4% 100 Search CYTARABINE Search CYTARABINE
6 POSTREMISSION THERAPY 19 76% 0% 13 Search POSTREMISSION+THERAPY Search POSTREMISSION+THERAPY
7 HIGH DOSE CYTARABINE 15 49% 1% 22 Search HIGH+DOSE+CYTARABINE Search HIGH+DOSE+CYTARABINE
8 VORELOXIN 15 88% 0% 7 Search VORELOXIN Search VORELOXIN
9 GEMTUZUMAB 13 71% 0% 10 Search GEMTUZUMAB Search GEMTUZUMAB
10 ACUTE MYELOGENOUS LEUKEMIA 11 13% 3% 79 Search ACUTE+MYELOGENOUS+LEUKEMIA Search ACUTE+MYELOGENOUS+LEUKEMIA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 HIGH DOSE CYTARABINE 275 59% 11% 305
2 ACUTE MYELOGENOUS LEUKEMIA 233 18% 41% 1165
3 ACUTE NONLYMPHOCYTIC LEUKEMIA 126 22% 18% 511
4 POSTREMISSION THERAPY 117 62% 4% 121
5 REMISSION INDUCTION CHEMOTHERAPY 93 91% 1% 39
6 COUNCIL AML11 TRIAL 88 82% 2% 51
7 POSTREMISSION CHEMOTHERAPY 86 77% 2% 59
8 TRIAL COMPARING IDARUBICIN 79 64% 3% 77
9 AML 10 TRIAL 74 62% 3% 76
10 INTENSIVE CHEMOTHERAPY 67 22% 9% 268

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet 2010 706 295 43%
Therapeutic Advances in Acute Myeloid Leukemia 2011 217 71 56%
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials 2009 244 39 69%
Management of older or unfit patients with acute myeloid leukemia 2015 2 51 84%
Acute myeloid leukaemia 2006 460 139 42%
Is it time to change conventional consolidation chemotherapy for acute myeloid leukemia in CR1? 2015 2 87 70%
Medical progress - Acute myeloid leukemia 1999 711 105 39%
Novel drugs for older patients with acute myeloid leukemia 2015 5 93 31%
Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia 2015 2 71 56%
Acute myeloid leukemia and myelodysplastic syndromes in older patients 2007 122 48 52%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 STEM CELL TRANSPLANTAT UNIT 5 18% 0.8% 24
2 HEMATOPOIET DISORDERS 4 67% 0.1% 4
3 OR LEUKAMIEDIAGNOST 3 57% 0.1% 4
4 LEUKEMIA DIAGNOST 3 20% 0.5% 15
5 HEMATOL L413 3 100% 0.1% 3
6 HOVON DATA 2 21% 0.4% 10
7 CYTOL IMMUNOL 2 67% 0.1% 2
8 EUROPEAN COOPERAT GRP BLOOD MARROW TRANSPLANTAT 2 67% 0.1% 2
9 HEMATOL TUMOR BANK 2 67% 0.1% 2
10 SERV ONCOL MALAD SANG 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000197189 FLT3//FLT3 ITD//NPM1
2 0.0000181260 URACIL ARABINOSIDE//ARA CTP//CYTOSINE ARABINOSIDE
3 0.0000158349 CLOFARABINE//CANC THER EUT IMMUNOL//NELARABINE
4 0.0000103324 MAJOR VAULT PROTEIN//LUNG RESISTANCE RELATED PROTEIN//VPARP
5 0.0000099224 LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL
6 0.0000098580 REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY
7 0.0000087874 BONE MARROW PURGING//MARROW PURGING//MAFOSFAMIDE
8 0.0000086091 ACUTE ERYTHROLEUKEMIA//PURE ERYTHROID LEUKEMIA//ACUTE ERYTHROID LEUKEMIA
9 0.0000083322 HEMATOGONES//BIPHENOTYPIC ACUTE LEUKEMIA//IMMUNOPHENOTYPING
10 0.0000076628 LEUKEMIC BLAST PROGENITORS//L CFU//500 SHERBOURNE ST